These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25093542)

  • 1. Interactive Monitoring Service and COPD: Is it Possible to Reduce Nonadherence?
    Blasi F; Raddi F; Miravitlles M
    COPD; 2015 Jun; 12(3):227-32. PubMed ID: 25093542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next?
    Bender BG
    Curr Opin Pulm Med; 2014 Mar; 20(2):132-7. PubMed ID: 24452102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.
    Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR;
    S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of chronic obstructive pulmonary disease.
    Ismail TS
    Med J Malaysia; 2009 Sep; 64(3):250-5; quiz 256. PubMed ID: 20527283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of primary care in early diagnosis and effective management of COPD.
    Bellamy D; Smith J
    Int J Clin Pract; 2007 Aug; 61(8):1380-9. PubMed ID: 17627713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease: getting it right. Does optimal management of chronic obstructive pulmonary disease alter disease progression and improve survival?
    Russell RE
    Curr Opin Pulm Med; 2014 Mar; 20(2):127-31. PubMed ID: 24434666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives.
    Ambrosino N; Paggiaro P
    Expert Rev Respir Med; 2012 Feb; 6(1):117-27. PubMed ID: 22283584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How have we been managing chronic obstructive pulmonary disease in Australia?
    Matheson MC; Abeysena C; Raven JM; Skoric B; Johns DP; Abramson MJ; Walters EH
    Intern Med J; 2006 Feb; 36(2):92-9. PubMed ID: 16472263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO; Hawkins C; Barbandi F
    J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of COPD exacerbations.
    Simoens S
    COPD; 2010 Jun; 7(3):159-61. PubMed ID: 20486812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Education of COPD patient--between pessimism and reserved optimism].
    Mihălţan F; Dragomir A; Ulmeanu R
    Pneumologia; 2006; 55(2):69-73. PubMed ID: 17069205
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a telehealth and care management program for patients with chronic obstructive pulmonary disease.
    Au DH; Macaulay DS; Jarvis JL; Desai US; Birnbaum HG
    Ann Am Thorac Soc; 2015 Mar; 12(3):323-31. PubMed ID: 25642649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease: diagnosis and management.
    Downs CA; Appel SJ
    J Am Acad Nurse Pract; 2007 Mar; 19(3):126-32. PubMed ID: 17341279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of direct medical costs of chronic obstructive pulmonary disease over 12 months].
    Stâmbu I; Stoicescu IP
    Pneumologia; 2013; 62(2):86-92. PubMed ID: 23894789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.